Contribution of Plasma Protease Inhibitors to the Inactivation of Kallikrein in Plasma
Although C̄l-inhibitor (C̄l-INH) and α(2)-macroglobulin (α(2)M) have been reported as the major inhibitors of plasma kallikrein in normal plasma, there is little quantitative support for this conclusion. Thus, we studied the inactivation of purified kallikrein in normal plasma, as well as in plasma...
保存先:
| 出版年: | J Clin Invest |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Society for Clinical Investigation
1982
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC370996/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/6173399/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI110470 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|